Lisa Egbuonu-Davis

Sits on 2 boards. Last updated September 28, 2026

Time on boards

Boards served
2
Current seats
2
Board service
7 years
Director since
2023

7 years of board service in total across 2 boards, counting each seat separately. Longest: Omega Healthcare Investors Inc., 3 years.

3 years · Since 2023
Phreesia Inc. Director
3 years · Since 2023

Shareholder support

Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Aug 7, 2026 Omega Healthcare Investors Inc. Gift −5,131 — —
Jul 14, 2026 Phreesia Inc. Open-market sale −536 $10.70 $5,735
Jun 25, 2026 Phreesia Inc. Open-market sale −2,546 $9.53 $24,263
Jun 24, 2026 Phreesia Inc. Grant or award +19,290 $9.59 $184,991
Jun 5, 2026 Omega Healthcare Investors Inc. Grant or award +3,778 $43.67 $164,985
Aug 8, 2025 Omega Healthcare Investors Inc. Open-market sale −200 $40.16 $8,032
Aug 8, 2025 Omega Healthcare Investors Inc. Open-market sale −2,300 $40.16 $92,368
Jul 15, 2025 Phreesia Inc. Open-market sale −465 $27.64 $12,853
Jun 26, 2025 Phreesia Inc. Open-market sale −2,802 $27.67 $77,531
Jun 25, 2025 Phreesia Inc. Grant or award +6,700 $27.61 $184,987
Jun 6, 2025 Omega Healthcare Investors Inc. Grant or award +4,388 $37.60 $164,989
Sep 12, 2024 Phreesia Inc. Open-market sale −1,400 $23.03 $32,242
Aug 13, 2024 Omega Healthcare Investors Inc. Open-market sale −1,352 $38.00 $51,376
Jun 26, 2024 Phreesia Inc. Grant or award +8,490 — —
Jun 7, 2024 Omega Healthcare Investors Inc. Grant or award +4,605 $32.57 $149,985

Questions about Lisa Egbuonu-Davis

What boards is Lisa Egbuonu-Davis on?

Lisa Egbuonu-Davis sits on the boards of Omega Healthcare Investors Inc. and Phreesia Inc.

How long has Lisa Egbuonu-Davis served on boards?

Our records show at least 7 years of board service across 2 boards, the earliest from 2023.

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.